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Abstract
Vitamin D deficiency is an epidemic in the United States. Uninsured women 
are at high risk due to a lower intake of vitamin D and limited sun exposure. 
We examined the association between vitamin D deficiency and hyperten-
sion in 96 uninsured women at a County Free Medical Clinic in urban Michi-
gan. Questionnaires were used to obtain information about demographics, 
medical history including hypertension, and dietary habits. Measurements 
including blood pressure and serum 25(OH)D level were also collected. 
Prevalence of hypertension was higher in subjects with 25(OH)D less than 
50nmol/l compared with others (85% vs. 27.3%, p = 0.014). For every 1 
nmol/L decrease in serum 25(OH)D, there was an increase in the systolic and 
diastolic blood pressure by 0.20 (p =0.006) and 0.13 (p =0.003) mm of Hg 
respectively. These results demonstrate a high prevalence of hypertension in 
the vitamin D deficient, uninsured female population
Key Words:  Vitamin D; Deficiency; Hypertension; uninsured; women
INTRODUCTION
According to the 2006 U.S. Census, there are now 47 million American 
citizens who do not have health insurance and the number is steadily 
increasing (www.urban.org). Uninsured adults are more likely than others to 
have untreated or uncontrolled hypertension (Ostchega, et al, 2008; Duru et 
al, 2007) and stroke (Fowler-Brown et al, 2007).  Among stroke sufferers, those 
without health insurance experience more neurological impairment, longer 
hospital stays and higher mortality than others (Shen et al, 2007).  
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We recently reported a high prevalence of vitamin D deficiency in a 
group of uninsured women living in the northern United States of America 
(Kakarala et al, 2007).   Several lines of evidence suggest that poor vitamin D 
status may be a risk factor for hypertension and stroke. People living at higher 
latitudes throughout the world, where skin production of vitamin D is limited, 
are at higher risk of developing hypertension than others (Rostand SG, 1997). 
Several observational studies have shown inverse correlations of vitamin 
D status, as determined from blood levels of 25-hydroxyvitamin D [25(OH)
D], with blood pressure or hypertension (Lind et al, 1995; Martins et al, 2007; 
Forman et al, 2007). Two independent cross sectional studies from the third 
National Health and Nutrition Examination Survey, reported this association 
across different ethnic groups (Scragg et al, 2007; Judd et al, 2008).  In one 
intervention study, supplementation with calcium and vitamin D resulted in a 
substantial (9%) decrease in systolic blood pressure in elderly women (Pfeifer 
et al, 2001).  Evidence from animal studies suggests that vitamin D may affect 
blood pressure through regulation of the renin-angiotensin system (Li et al, 
2004). 
We conducted the present analysis to determine whether vitamin D 
status in our population of uninsured women receiving their health care 
at a community based free clinic is associated with blood pressure or 
hypertension status.  If so, this study would provide preliminary evidence 
that addressing the poor vitamin D status of uninsured adults might reduce 
morbidity and mortality from hypertension and stroke.
METHODS
Subjects and study design
The design and data-collection methods for this study have been 
reported previously (Kakarala et al, 2007). The study was approved by the 
Institutional Review Board for human subjects, and all patients gave written 
informed consent to participate in the study. This is a cross-sectional study 
of uninsured women aged 18 to 64 years receiving medical care from a 
County Free Clinic in urban Michigan during the period of 2005 to 2006.  The 
exclusion criteria included known significant renal or hepatic dysfunction, 
diseases associated with significant malabsorption, use of prescription 
vitamin D, pregnancy, treatment with medications that interfere with vitamin 
D metabolism, or substantial discrepancies between self-reported medical 
status and medical record information. 
Two investigators recruited the subjects three days a week using a 
standardized case report form. Of the 155 eligible patients, 145 women, all 
uninsured, provided written informed consent and were enrolled. Assessment 
of vitamin D status required a separate laboratory visit, and 49 of the 145 
enrolled patients were unwilling or unable to return for that visit. The 96 
patients with known vitamin D status were included in this analysis. As 
previously reported (Kakarala et al, 2007), there were no significant differences 
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between the 49 women who were unwilling to return for the laboratory visit 
and the 96 who were eventually enrolled with respect to race, vitamin D intake, 
sun exposure and body mass index. However the enrolled subjects were an 
average of 5 years older than those women that were excluded. 
Measurements
Hypertension diagnosis was defined as a positive response by the 
patients to a question on an administered health questionnaire. This question 
asked patients whether a clinician had diagnosed hypertension in them. 
The reliability of self-reported hypertension has been shown in previous 
epidemiological studies (Vargas et al, 1999), but we nevertheless verified 
hypertension diagnosis and treatment by review of the medical records. All 
the subjects with hypertension were prescribed anti-hypertensive medications 
as confirmed by chart review. They obtain their medication monthly at the 
free clinic, after consultation with a physician, for proper control of their blood 
pressure. Blood pressure was measured with a sphygmomanometer with an 
appropriate sized cuff, after asking the subjects to sit quietly for a few minutes. 
Systolic and diastolic blood pressures were taken at Korotkov sounds I and V. 
Information about demographics including age, height, weight, body mass 
index (BMI: calculated as weight in kilograms divided by height in meters 
squared) race, health status, multivitamin, vitamin D supplementation, sunlight 
exposure and dietary habits were ascertained from the health questionnaire. 
Height was self-reported. A validated short food frequency screening 
instrument was used to assess dietary vitamin D and calcium intakes (Blalock et 
al, 2003). Serum 25(OH)D levels were measured with direct radioimmunoassay 
(using a Diasorin radioimmunoassay kit) and reported as nmol/l (multiply 
nmol/L by a conversion factor of 2.496 to obtain ng/ml). Vitamin D deficiency 
was defined as a serum 25(OH)D concentration less than 50 nmol/L (20 ng/ml) 
for consistency with a prior study in the same subjects (Kakarala et al, 2007) 
and to allow for comparison of our subjects with the representative NHANES III 
population (Looker et al, 2002). Serum total calcium level was measured using 
standard automated calorimetric method.
Data Analysis
The biostatistical evaluation was carried out using the SPSS 14.0 statistical 
package (SPSS Inc., Chicago, IL). A descriptive statistical analysis was made, 
including measurements of central tendency and spread for quantitative 
variables. Chi-square and student “t” tests were used to compare the variables 
between different groups.  Pearson correlation coefficients were calculated to 
assess simple linear associations of 25(OH)D with other variables. A series of 
multiple linear regression analyses were performed to describe the association 
between serum 25(OH)D levels and blood pressure and to adjust for other 
determinants of blood pressure (age, BMI, race, calcium intake and vitamin 
D intake). A multiple logistic regression analysis was performed in order to 
describe the association of 25(OH)D with hypertension after adjustment for 
other variables. Statistical significance was established as a P value of 0.05.     
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RESULTS
Characteristics of the study subjects
Characteristics of the 96 subjects are shown in Table 1. Subjects with 
lower serum 25(OH)D levels tended to be older and have a higher BMI than 
those who are non-deficient, however there was no statistically significant 
difference between the groups. Vitamin D deficiency was more prevalent in 
African- American women than in others, and subjects with higher serum 
25(OH)D levels were consuming more calcium and vitamin D through their 
diet. 
Association of serum 25(OH)D with hypertension
Hypertension was present in 65% (62 out of 96) of the subjects and 
its prevalence decreased across categories of increasing 25(OH)D (Table 
1).  Similarly, 25(OH)D was significantly lower among hypertensive than 
normotensive subjects (59.4±33.2 vs. 38.9±20.8 nmol/l, P<0.001).  
Table 1. Characteristics of participants (N = 96) according to the serum 25 
(OH)D status. Variable values are shown as mean±SD
Variable Serum 25(OH)D (nmol/L) P-value
 ≤22.5  
(n=20)
22.6 - 37.5
(n=25)
37.6 - 50.0
(n=19)
50.1 - 79.9
(n=21)
≥80.0
 (n=11)
25 (OH)D* 18.4±4.4 30.1±3.8 45.3±5.7 60.5±8.4 107.2±16.0 <0.001
Age (Yrs) 51.7±9.2 47.5±8.9 51.1±9.4 46.2±13.7 46.2±13.7 0.145
BMI (Kg/m2) 34.4±6.6 31.9±9.0 35.7±7.4 31.2±9.6 30.2±7.8 0.186
SBP** 139.3±21.2 132.2±16.0 131.7±15.3 123.2±15.9 115.6±14.8 0.002
DBP** 80.1±12.4 82.5±10.4 78.2±9.7 76.3±13.2 70.7±7.7 0.053
Vitamin D¶ 72±56 116±111 142±102 174±131 166±119 0.029
Calcium§  402±174 591±373 825±595 741±420 701±382 0.019
Race (n, (%)) <0.001
Caucasian 4 (20.0) 15 (60.0) 15 (79.0) 19 (90.4) 11 (100.0)
AA 13 (65.0) 6 (24.0) 2 (10.5) 0 (  0.0) 0 (    0.0)
Hispanic 1 (  5.0) 2 (  8.0) 0 (  0.0) 1 (  4.8) 0 (    0.0)
NA 1 (  5.0) 0 (  0.0) 0 (  0.0) 1 (  4.8) 0 (    0.0)
Other 1 (  5.0) 2 (  8.0) 2 (10.5) 0 (  0.0) 0 (    0.0)
Hypertension 17 (85.0) 17 (68.0) 14 (73.7) 11 (52.4) 3 (  27.3) 0.014
*Serum 25(OH)D levels in nmol/L; BMI = Body mass index; SBP = Systolic blood pressure; DBP = 
Diastolic blood pressure; **Blood pressure in mm of Hg; ¶Vitamin D intake in IU/day; §Calcium 
intake in mg/day; Vitamin D and calcium intake were calculated from food questionnaires; AA = 
African American; NA = Native American
 
 47
We performed logistic regression analyses in order to determine whether   
this association remained after adjustment for potential confounders 
including age, race, BMI and calcium intake. In this analysis, (Table 2) the odds 
ratio for 25(OH)D (included as a continuous variable) was 0.96, indicating 
a  4% reduction in risk of hypertension for each 1 nmol/L increase in serum 
25(OH)D.
Table 2. Independent predictors of hypertension in 96 women
Variable Odds Ratio    95% CI P-Value
Serum 25(OH)D* 0.963 0.937 - 0.989 0.006
Age (years) 1.127 1.054 - 1.205  <0.001
BMI (Kg/m2) 1.192 1.087 - 1.307  <0.001
Race
Non-Caucasian 1.720 0.397 - 7.450 0.469
Caucasian (Reference Group)
Calcium Intake (mg/d) 0.999 0.998 - 1.001 0.447
*Serum 25(OH)D level in nmol/L, BMI = Body Mass Index 
Association of serum 25(OH)D levels with blood pressure
Both systolic and diastolic blood pressure decreased across categories 
of increasing serum 25(OH)D level (Table 1). There was a negative correlation 
between serum 25(OH)D and blood pressure [systolic (r= -0.40, p < 0.001) 
and diastolic (r= -0.31, P= 0.002)] (Figure 1).  Although all the hypertensives 
in this study were being treated for their condition their blood pressure 
remained significantly higher than that of the normotensive subjects (136±16 
vs. 117±1, P<0.001 for systolic blood pressure and 80±12 vs. 75±10, P= 0.036 
for diastolic blood pressure).   In order to determine whether the association 
of 25(OH)D with blood pressure differed between normotensives and treated 
hypertensives, we included a 25(OH)D by hypertension status interaction 
term in regressions of 25(OH)D on systolic and diastolic blood pressure while 
also controlling for age, race, BMI and calcium intake.  The interaction terms 
were not statistically significant for systolic (P=0.695) or diastolic (P=0.598) 
blood pressure and were removed in subsequent regressions.  The effects 
of adding potential confounders as independent variables in regressions 
of systolic and diastolic blood pressure on 25(OH)D are shown in table 3.  
Regression coefficients for 25(OH)D in relation to systolic blood pressure 
and diastolic blood pressure were -0.20 (P= 0.006) and -0.13 (p = 0.003) 
respectively, after adjustment for age, BMI, race and calcium intake. In other 
words, for every 1 nmol/L decrease in serum 25(OH)D, there is an increase 
in the systolic and diastolic blood pressure by 0.20 and 0.13 mm of Hg 
respectively. 
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DISCUSSION
In our earlier paper (Kakarala et al, 2007), we reported that two thirds of 
the uninsured women in our study population were vitamin D deficient as 
defined by a serum 25(OH)D level less than 50 nmol/L.  In the present analysis 
we found that both blood pressure and the prevalence of hypertension 
decreased with increasing 25(OH)D levels in this group, and these associations 
were independent of age, BMI, and race.  Although this association has been 
observed in other populations (Foreman et al, 2007; Sowers et al, 1987), it 
may be of particular importance among uninsured adults because it suggests 
a potential route for preventing hypertension that is inexpensive and not 
dependent on formal medical care.  As we reported previously, the non-
Caucasian women in this study, most of whom were African-American, were 
three times more likely than Caucasian women to have 25(OH)D levels under 
50 nmol/L (Kakarala et al, 2007).  Scragg et al (2007), recently reported that 
racial differences in 25(OH)D explained about half the increased hypertension 
prevalence of black compared with white participants in NHANES III.  Judd et 
al (2008), analyzed the NHANES III data somewhat differently and reported 
a significant interaction of race with 25(OH)D indicating no association of 
25(OH)D with blood pressure in blacks (Judd et al 2008).  More work is needed 
to fully understand the contribution of poor vitamin D status to increased 
hypertension in blacks, particularly because most observational studies, 
including ours, lacked sufficient numbers of black participants with high 
25(OH)D concentrations to fully explore the benefit of vitamin D repletion 
in this group.  However, given the mounting evidence of a role for vitamin D 
in preventing numerous chronic and infectious diseases, many of which are 
more prevalent in persons of color (Harris  et al 2006), improving the poor 
vitamin D status of African-Americans should be an important public health 
priority.
The finding of an inverse association between 25(OH) D and blood 
pressure, in our study, supports the cumulative evidence of various 
epidemiological and clinical data from the past decade. Animal model studies 
demonstrate that vitamin D is a negative endocrine inhibitor of the renin-
angiotensin II system and plays a role in the regulation of blood pressure and 
volume homeostasis (Li et al, 2004).  A recent study by Zhou et al  also showed 
that 1,25(OH)2D might play an important role in cardiovasular health by 
repressing the renin-angiotensin system, independent of extracellular calcium 
or phosphorus ( Zhou C et al, 2008). 
Intervention studies are needed to establish a firm causal link between 
vitamin D status and hypertension.  However, given the growing evidence 
of widespread vitamin D deficiency (Looker et al, 2002) and its association 
with numerous chronic conditions (Holick et al, 2007) and increased mortality 
(Melamed et al, 2008), it is not premature to encourage uninsured individuals, 
like others, to increase their vitamin D intake.  Although the optimal 25(OH)
D concentration to prevent hypertension is unknown, a level of at least 75-
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80 nmol/L is considered optimal for multiple health outcomes (Holick et al, 
2007; Bischoff-Ferrari HA et al, 2008).  Most experts now feel that 1000 IU/d or 
more are needed for adults in northern areas to maintain adequate vitamin 
D levels year round (Dawson-Hughes et al, 2005; Holick et al, 2008), much 
more than the 100-200 IU/d consumed by most of our subjects. The safety 
of doses as high as or higher than 1000 IU/d is well established (Vieth et al, 
2007).  In summary, the prevention and treatment of vitamin D deficiency 
may be one way to reduce the risk for and consequences of hypertension in 
the vulnerable uninsured population. 
CONCLUSIONS
These results demonstrate a high prevalence of hypertension in a vitamin 
D deficient, uninsured, medically underserved female population. Uninsured 
women should be strongly encouraged to increase their vitamin D intake 
to control their hypertension, along with therapeutic lifestyle changes and 
medications. 
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